164 related articles for article (PubMed ID: 33678230)
1. Achieving equity in cervical cancer screening in low- and middle-income countries (LMICs): Strengthening health systems using a systems thinking approach.
Gravitt PE; Silver MI; Hussey HM; Arrossi S; Huchko M; Jeronimo J; Kapambwe S; Kumar S; Meza G; Nervi L; Paz-Soldan VA; Woo YL
Prev Med; 2021 Mar; 144():106322. PubMed ID: 33678230
[TBL] [Abstract][Full Text] [Related]
2. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
3. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
4. Implementation research to accelerate scale-up of national screen and treat strategies towards the elimination of cervical cancer.
Broutet N; Jeronimo J; Kumar S; Almonte M; Murillo R; Huy NVQ; Denny L; Kapambwe S; Bhatla N; Sebitloane M; Zhao F; Gravitt P; Adsul P; Rangaraj A; Dalal S; Newman M; Chowdhury R; Church K; Nakisige C; Diop M; Parham G; Thomson KA; Basu P; Steyn P
Prev Med; 2022 Feb; 155():106906. PubMed ID: 34896155
[TBL] [Abstract][Full Text] [Related]
5. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
Pimple SA; Mishra GA
Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
[TBL] [Abstract][Full Text] [Related]
6. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.
Okeah BO; Ridyard CH
Appl Health Econ Health Policy; 2020 Oct; 18(5):641-654. PubMed ID: 32468410
[TBL] [Abstract][Full Text] [Related]
7. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
[TBL] [Abstract][Full Text] [Related]
8. Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Wirtz C; Mohamed Y; Engel D; Sidibe A; Holloway M; Bloem P; Kumar S; Brotherton J; Reis V; Morgan C
Vaccine; 2022 Mar; 40 Suppl 1():A116-A123. PubMed ID: 34863615
[TBL] [Abstract][Full Text] [Related]
9. Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis.
Camara H; Zhang Y; Lafferty L; Vallely AJ; Guy R; Kelly-Hanku A
BMC Public Health; 2021 Aug; 21(1):1503. PubMed ID: 34348689
[TBL] [Abstract][Full Text] [Related]
10. Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era.
Woo YL; Gravitt P; Khor SK; Ng CW; Saville M
Prev Med; 2021 Mar; 144():106294. PubMed ID: 33678225
[TBL] [Abstract][Full Text] [Related]
11. Towards the global elimination of cervical cancer.
Canfell K
Papillomavirus Res; 2019 Dec; 8():100170. PubMed ID: 31176807
[TBL] [Abstract][Full Text] [Related]
12. Cervical Cancer Prevention in Low- and Middle-Income Countries.
Allanson ER; Schmeler KM
Clin Obstet Gynecol; 2021 Sep; 64(3):501-518. PubMed ID: 34120126
[TBL] [Abstract][Full Text] [Related]
13. A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities.
Shin MB; Liu G; Mugo N; Garcia PJ; Rao DW; Bayer CJ; Eckert LO; Pinder LF; Wasserheit JN; Barnabas RV
Front Public Health; 2021; 9():670032. PubMed ID: 34277540
[TBL] [Abstract][Full Text] [Related]
14. Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators.
Spayne J; Hesketh T
BMJ Open; 2021 Sep; 11(9):e052016. PubMed ID: 34475188
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
Cubie HA; Campbell C
Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
[TBL] [Abstract][Full Text] [Related]
18. Innovative approaches to cervical cancer screening in low- and middle-income countries.
Toliman PJ; Kaldor JM; Tabrizi SN; Vallely AJ
Climacteric; 2018 Jun; 21(3):235-238. PubMed ID: 29488817
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
